- Home
- IMUX vs SEVN Comparison
IMUX vs SEVN Comparison
Compare IMUX & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMUX | SEVN |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 190.3M |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | IMUX | SEVN |
|---|---|---|
| Price | $14.77 | $8.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $36.00 | $10.50 |
| AVG Volume (30 Days) | ★ 182.6K | 150.4K |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $43.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $7.90 |
| 52 Week High | $15.84 | $11.44 |
Technical Indicators
Market Signals| Indicator | IMUX | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 49.62 |
| Support Level | $0.74 | $8.05 |
| Resistance Level | $15.81 | $8.89 |
| Average True Range (ATR) | 0.90 | 0.23 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 40.69 | 25.60 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.